1. Protective effect of Berberis aristata against peritonitis induced by carbapenem-resistant Escherichia coli in a mammalian model
- Author
-
Rakesh Sharma, Pallavi Thakur, Raman Chawla, and Alka Narula
- Subjects
Male ,0301 basic medicine ,Microbiology (medical) ,Berberis ,No-observed-adverse-effect level ,030106 microbiology ,Immunology ,Peritonitis ,Berberis aristata ,Urine ,Pharmacology ,Kidney ,medicine.disease_cause ,Microbiology ,Mass Spectrometry ,Rats, Sprague-Dawley ,03 medical and health sciences ,0302 clinical medicine ,In vivo ,Escherichia coli ,medicine ,Animals ,Immunology and Allergy ,030212 general & internal medicine ,Escherichia coli Infections ,biology ,Plant Extracts ,Isoquinolines ,medicine.disease ,biology.organism_classification ,Antimicrobial ,Anti-Bacterial Agents ,Multiple drug resistance ,Disease Models, Animal ,Blood ,Carbapenem-Resistant Enterobacteriaceae ,Treatment Outcome ,Blood Chemical Analysis ,Chromatography, Liquid - Abstract
Objectives Berberis aristata is known to contain a variety of phenolic compounds contributing to its holistic capability of mitigating bacterial multidrug resistance. Methods B. aristata stem bark extract was prepared and was characterised using liquid chromatography–mass spectrometry (LC–MS). The antimicrobial efficacy of the extract against carbapenem-resistant Escherichia coli was assessed in vivo in an animal model using Sprague Dawley rats. Microbial counts in blood and urine, physical health status, haematological and biochemical analysis of blood, and histopathology of the kidney were assessed as the study endpoints. Results An aquo-alcoholic extract of B. aristata (PTRC-2111-A) was found to effectively manage peritonitis induced by carbapenem-resistant E. coli in a rat model at a single post-exposure prophylactic dose of 0.5 mg/kg body weight (BW). The extract was also found to show a no observed adverse effect level (NOAEL) up to a dose of 2000 mg/kg BW. Physical, immunological, haematological, biochemical and histopathological aberrations were found to be restored to normal in the herbal-treated group at a dose of 0.5 mg/kg BW. Conclusions The antimicrobial and hepatorenal protective ability of PTRC-2111-A could be attributed to the presence of isoquinoline alkaloids.
- Published
- 2017
- Full Text
- View/download PDF